Stay updated on Pembrolizumab SubQ vs IV in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4 in the footer, replacing Revision: v3.6.3, indicating a platform/UI update.
    Difference
    0.1%
    Check dated 2026-07-25T18:03:10.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating a small behind-the-scenes platform version update. This change does not alter study data or visible features.
    Difference
    0.1%
    Check dated 2026-07-04T05:00:52.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.6.2 appears in the page history, replacing the previous Revision: v3.6.0. This reflects a minor update to the revision metadata of the record and does not change study data or public content.
    Difference
    0.1%
    Check dated 2026-06-27T03:06:56.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    A new revision v3.6.0 adds a note that the study is no longer looking for participants, and the previous revision v3.5.5 is removed from the history.
    Difference
    0.3%
    Check dated 2026-06-12T16:11:18.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    New revision v3.5.5 is added to the study history, replacing the previous revision v3.5.4. This indicates an update to the record's version rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-06-05T12:34:21.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    A new site revision entry (v3.5.4) was added and the previous revision (v3.5.3) removed in the record history, signaling a platform update to the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-05-14T23:17:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab SubQ vs IV in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.